Last weekmarket in 10 stocks: Jetdescent JPAbig plunge

INSUBCONTINENT EXCLUSIVE:
NEW DELHI: The week gone by was an eventful one as the benchmark indices scaled record highs despite concerns over global trade war
For the week, BSE barometer Sensex climbed 313 points, or 0.83 per cent, to settle at 37,869 after hitting a record high of 38,076 during
the week. NSE's benchmark Nifty50 gained 68.70 points, or 1.01 per cent, during the week to 11,429
It fell short of the 11,500 level, but madeba fresh all-time high of 11,495 on Thursday. Here's a list of stocks that hogged limelight
shareholders who are losing money amid the company's ongoing financial woes
The company has made u-turn on 25 per cent salary cut for employees, and on Thursday't was deferred its earnings announcement to an
unspecified late date
The stock wiped 10.44 per cent off Jet shareholders' wealth during the week
HDFC AMC: This stock gained 49 per cent from its issue price during its listing week
The stock on Friday closed at Rs 1,749.30 against its listing price of Rs 1,739 and issue price of Rs 1,100
The Rs 2,800 crore initial public offering (IPO) was sold between July 25 and 27, and was subscribed 83 times. Selan Exploration Technology:
This scrip rose 25 per cent last week
Ace investor Dolly Khanna picked up additional stake in the company during the week
According to the data, Khanna bought 1,04,250 shares at Rs 244.03 apiece, amounting to over Rs 2.5 crore
The company on Wednesday reported a 320 per cent growth in net profit at Rs 14.25 crore against Rs 3.39 crore reported for the year-ago
period. JP Associates: This stock plunged 12 per cent in the week gone by after the Supreme Court said that the promoters of Jaiprakash
Associates cannot bid for Jaypee Infratech, which is facing insolvency proceedings before the National Company Law Tribunal (NCLT)
The court has referred the case back to the insolvency court to start the process afresh under a new committee of creditors that includes
homebuyers. Kwality: Strange as it seems, this stock jumped 28 per cent last week, even as dairy products maker delayed reporting its
financial results for the quarter ended June citing technical snag
software, financial results for June quarter is delayed for finalisation. PVR: This stock soared 12 per cent last week after the Maharashtra
government filed an affidavit at the Bombay High Court, saying it does not deem it necessary to interfere with the ban on outside food in
multiplexes
Meanwhile, reports of the Supreme Court staying a Jammu Kashmir High Court order allowing outside food to be taken in cinema halls too
boosted the counter. Reliance Communications: This stock gained 19.49 per cent last week on reports the debt-ridden operator is looking to
complete the sale of its business assets worth Rs 25,000 crore by the end of this month
During the week, the company said it would launch an offer to buy back $300 million of overseas bonds as part of a proposed debt
restructuring
Besides, the Anil Ambani-led telco has got one more month to furnish bank guarantees worth Rs 774 crore to telecom department and sell
spectrum to Jio. AU Small Finance Bank: This stock gained 6 per cent for the week
Global investor Redwood Investment today sold over 8 per cent stake in AU Small Finance Bank for Rs 1,531 crore, through open market
transactions
Among the buyers of the shares were AU Small Finance Bank's promoter Sanjay Agarwal, SBI Mutual Fund, Nomura India Investment Fund Mother
Fund, Reliance Mutual Fund and Sundaram Mutual Fund
Avanti Feeds: The stock fell 10.64 per cent for the week after the company reported 41.59 per cent year-on-year fall in net profit at Rs
85.67 crore for the quarter ended June 2018
It had posted a net profit of Rs 146.68 crore in the same quarter last year
Revenue from operations increased to Rs 1,040.24 crore in Q1 FY19 over Rs 998.17 crore in Q1 FY18
Lupin: This stock fell 8.64 per cent for the week after the drug firm reported 43.37 per cent decline in its consolidated net profit at Rs
202.76 crore for the first quarter ended June 30, hit by drop in sales in the US and Japan
The pharma company posted a net profit of Rs 358.08 crore in the year-ago quarter.